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Abstract 
We have previously demonstrated that polypeptides (elcatonin and ACTH) can be actively absorbed across the rabbit nasal mucosa. In 
this paper we show that elcatonin is also transported when it is adsorbed onto microspheres (diameter: 0.5 I~m), whereas the 
elcatonin-uncovered microspheres do not display any net transport. Cytochalasin D (0.1 txg/ml) abolishes the net absorption of elcatonin 
presented either alone or adsorbed. At the same concentration the inhibitor does not affect cellular active ion transports (and hence 
metabolism); although it increases intercellular ion and elcatonin permeability, it does not affect intercellular and paracellular permeability 
of the elcatonin-covered microspheres. ALtogether, these results show that polypeptide transport is supported by a specific vesicular 
transfer inhibited by cytochalasin D by disassembly of the actin cytoskeleton, probably at the apical border of the cell. 
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1. Introduction 
We have previously shown that a specific, active trans- 
port of polypeptides (perhaps involved in antigen sampling 
from nasal lumen to blood) is present in the nasal respira- 
tory mucosa of the rabbit [1]. The transcellular active 
transport of macromolecules is generally based on vesicu- 
lar transport which in principle can result from fluid-phase 
nonspecific endocytosis (pinocytosis) or receptor-mediated 
endocytosis [2]; however, the macromolecule transport is 
generally specific. At the apical membrane of the epithelial 
cells the vesicle formation for both processes requires the 
action of an actin-microfilament network [3] which can be 
specifically disassembled by cytochalasin D [3-5]. Thus, 
as for the active transfer of polypeptides observed, it may 
be predicted that: ( I)  the test-molecule, presented adsorbed 
on microparticles, should be equally actively transported, 
(2) this transfer on microparticles hould be specific, (3) 
the net transfer of the test-molecule, ither presented alone 
or adsorbed on microparticles, should be inhibited by 
cytochalasin D. 
The aim of this paper is to examine these points, to 
establish whether the active transport observed in the nasal 
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mucosa is supported by specific vesicular transport. Cy- 
tochalasin D and polystyrene microspheres, covered with 
the test molecule, were used as the investigation tool. The 
microsphere diameter (0.5 I~m) was compatible with vesic- 
ular transport, based on pinocytosis or receptor-mediated 
endocytosis [6]. 
2. Materials and methods 
Male New Zealand rabbits (weighing about 3 kg) were 
killed by cervical dislocation; the fore-half nasal mucosae 
from both nostril roofs were excised, washed with Krebs- 
Henseleit saline at room temperature and mounted between 
two teflon chambers (exposed area: upper concha, 0.3 
cm2). Each chamber was filled with 1 ml Krebs-Henseleit 
saline, bubbled with prehumidified 95% 0 2 + 5% CO 2 to 
oxygenate the tissue, to maintain pH at 7.4 and to agitate 
the solution. The experiments were carried out at open 
electrical circuit and at 27_  I°C as at this temperature 
mucosa functionality not only does not degrade, but also 
improves with time for many hours [7]. 
As for transepithelial flux measurements the test-mole- 
cule used was elcatonin ([1,7 Asu] eel calcitonin; carbocal- 
citonin, CCT; Mw = 3362). It was determined by radioim- 
munoassay (RIA), so as to measure only the intact or 
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nearly intact molecule (Ref. [1] 1), with the aid of a 
~-counter (Autogamma 800C, Packard Instr. Co., Meriden, 
CT, USA). Teflon chambers were used to avoid surface 
adsorption of the polypeptide molecules. The unidirec- 
tional mucosa-submucosa and opposite fluxes (Tm~, T~m) 
were determined one on the right, the other on the left 
mucosa from the same animal (with random combinations), 
the functional symmetry of the mucosae having been 
demonstrated in advance [1,7]. After a 30-min preincuba- 
tion to allow the tissue to recover after isolation, 1 ml 
saline was introduced with the test molecule (20 Izg/ml) 
into the mucosal or submucosal chamber (donor chamber) 
and the appropriate transepithelial flux subsequently deter- 
mined after a 2-h incubation, by complete withdrawal of 
the saline. Both fluxes were considered unidirectional since 
the maximal concentration reached in the flux chamber 
was 10-3-10 -5 compared to that applied in the opposite 
donor chamber. On the basis of 25-txl samples taken every 
30 min, the elcatonin concentration i the donor chamber 
originating the flux was observed to decrease slightly with 
time. The metabolized fraction over the 2-h period was at 
most 17%. Although this value was relatively small, the 
transports actually measured were corrected by multiplying 
their value by the ratio between the initial elcatonin con- 
centration and the mean concentration during the 2-h 
period (see also Ref. [1]). The viability of the preparation 
was checked at the beginning and end of the experiment 
by measuring the transepithelial electrical potential differ- 
ence (Vm~): tissues with initial Vm~ less than +1 mV 
(submucosa positive) were discarded [1,7]. 
In some experiments, after the 30-min preincubation, 
elcatonin was introduced (into the mucosal or submucosal 
chamber) adsorbed on polystyrene microspheres made flu- 
orescent with fluoresceinisothiocyanate (FITC) (Polysci- 
ence Inc., Warrington, PA, USA); their diameter was about 
L Carbocalcitonin s composed of 32 amino acids and is prepared from 
eel calcitonin by replacing the disulphide bridge (closing the 1-7 ring) 
with an ethylene bridge: this makes it stable at 37°C in the absence of 
proteases. The polyclonal antibody used for RIA was specifically raised 
against CCT. It does not react with human and porcine calcitonin and 
displays less than 20% cross-reactivity with eel and salmon calcitonin. Its 
target is in the 1-15 part of the molecule. The antibody does not react 
with all the possible 11-32 fragments (11-32, 15-32, 20-32, 24-32, 
27-32). Conversely, it displays 100% cross-reactivity with 1-11 and 1-18 
fragments. If, on the action of proteases present in the nasal mucosa 
fragments recognizable by the antibody were formed, in particular on the 
luminal side, the measured net flux of CCT [1] might be the result of 
these metabolites diffusing faster from the mucosal to the submucosal 
side than the unchanged CCT. However, we have shown [1] that CCT net 
flux is abolished in the presence of monoiodoacetate and dinitrophenol, 
inhibiting cellular ATP production without any likely interference with 
protease activities; under these conditions Jsm is not modified, but Jms is 
reduced to overlap it. Hence, in spite of the fact that slight CCT 
degradation is observed uring the experiment (see Ref. [1] and further in 
this paper), Jnet is not related to CCT fragments and their passive 
diffusion. 
0.5 I~m. The final concentration i  the donor chamber was 
about 3.5.10 H microspheres/ml. The actual concentra- 
tion of the microspheres was measured on 25-1xl samples 
(taken at the beginning and end of the experiment) with 
the aid of a Luminescence spectrometer (Ls 50, Perkin- 
Elmer Corp., Norwalk, CT, USA) and a calibration 
straight-line (excitation wavelength, 440 nm; emission 
wavelength, 485 nm). The reference microsphere concen- 
trations were predetermined by a Burker's chamber after 
adequate dilution, with microspheres observed by a fluo- 
rescence microscope (400x, Orthoplan MPV2, Leitz 
GMBH, D-6330 Wetzlar, Germany). During the experi- 
ment the initial and final bead concentrations proved not to 
be significantly different (initial concentration: (3.5 + 0.1) 
• 1011 microspheres/ml, n = 30; final concentration: (3.4 
___ 0.0) • 10 jl microspheres/ml, n = 30). The micro- 
spheres transported in the 2-h experiment were measured 
exclusively by Burker chamber due to their very low 
concentration. 
Elcatonin was adsorbed on microspheres by a method 
previously set up [8]. Briefly, a 510-1xl volume of native 
microsphere suspension was spun down at 11 000 rpm for 
10 min, the precipitate resuspended in 510 Ixl of Krebs- 
Henseleit saline containing 22 p~g/ml CCT (6.5 • 10 -6  M)  
and then incubated for 90 min at 37°C. Successively, to 
block still unbound bead sites, the CCT-coated micro- 
spheres were washed four times with Krebs-Henseleit saline 
containing 5% (w/v)  bovine serum albumin (BSA). Fi- 
nally, the BSA saline was removed and replaced with a 
Krebs-Henseleit saline. 
In one set of experiments, the microspheres used were 
not covered by elcatonin. Since under these conditions, 
when placed in the Krebs-Henseleit saline, they tend to 
adsorb and aggregate, both donor saline and saline with 
transported beads were sonicated at the beginning and end 
of the experiment, just before carrying out the determina- 
tions. Moreover, the donor saline was completely with- 
drawn and renewed every 30 min, this operation being 
proved sufficient o maintain a constant free bead concen- 
tration. 
The transepithelial e ectrical potential difference (Vm~) 
and short-circuit current (l~c) were measured using an 
automatic device (S. H~nin, Milano) that allowed auto- 
matic subtraction of the bathing fluid resistance for correct 
measurement of I~c. Bridges of 3% agar/3 M KCI and 3% 
agar/Krebs-Henseleit saline were used for the Vm~ and I~c 
determinations respectively. The transepithelial e ectrical 
res i s tance  (Rep) was calculated as the Vms/l~ ratio. 
The Krebs-Henseleit saline had the following composi- 
tion (mM): 142.9 Na +, 5.9 K +, 2.5 Ca 2+, 1.2 Mg 2+, 127.7 
CI-, 24.9 HCO 3, 1.2 SO 2-, 5.5 glucose. The cytochalasin 
D was previously dissolved in ethanol and added with it to 
the saline (2.5 ~1 ethanol/ml); at this concentration, 
ethanol alone had no effect on Vm~ for at least 150 min (5 
experiments). Cytochalasin D was supplied by Sigma (St. 
Louis, MO). Elcatonin and its antibody were kindly do- 
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nated by ISF Laboratories for Biomedical Research (Trez- 
zano s/N,  Milan, Italy); elcatonin labeling was carried out 
by Calbiochem Nova Biochem (Nottingham, UK). 
The results are expressed as means + standard errors; 
Student's t-test for unpaired ata or, when possible, paired 
data, was used for statistical analysis of the results reported 
in Table 1 ; conversely, the one-way ANOVA test was used 
to statistically analyze the data in Fig. 1. 
3. Results 
Tables 1 and 2 show the results of experiments in 
which elcatonin unidirectional and net transports were 
determined by presenting the polypeptide to the epithelium 
either alone or adsorbed on microspheres of 0.5 txm 
diameter. Since net elcatonin transport was observed to be 
exhausted in 2 h [1 ], the overall unidirectional (Tm~, T~m) or 
net (Tn~ t) transfers during this period were reported in the 
two tables. The net absorption from nasal lumen to blood 
was observed not only when the polypeptide was presented 
alone (Table 1), as expected, but also when it was ad- 
sorbed on microspheres (Table 2). In the former case the 
transport is specific for polypeptides [1]; similarly in the 
latter case the transfer of microspheres i strictly depen- 
dent on the polypeptide covering, since no significant T,~ t
was measured with native CCT-uncovered microspheres 
(Table 2). 
The effects of cytochalasin D are also shown in the two 
tables (experimental protocol: treatment on both sides of 
the tissue for the whole experiment, beginning just after 
Vm~ was measured at zero min time to check the viability 
of the mucosa). With 0.1 Ixg/ml (2. 10 -7 M)  inhibitor 
Table 1 
Effect of cytochalasin D (0.1 txg/ml) on the overall transepithelial 
transport of elcatonin (CCT) during the two experiment hours 
CCT transport (ng cm 2 ) 
Control Cytochalasin D
T~ 21.6±3.0 °° 22.6±2.0 
(18) (ll) 
~ 9.4±0.4 23.6±2.4"" 
(18) (ll) 
~t 12.2±3.2" -0 .8±3.0  
(18) (1]) 
After 30 min preincubation 20 Ixg/ml CCT was added to the mucosal or 
submucosal chamber and the overall corresponding unidirectional trans- 
ports during 2 hours (Tm~, T~m) were determined by RIA. Based on their 
difference the overall net transport (T,~) was calculated. When present, 
cytochalasin D was on both sides of the tissue during the 30 min 
preincubation and 2 h subsequent incubation. 
Results presented as means ± S.E. (number of experiments in parenthe- 
ses). 
P < 0.01 compared the respective ~m" 
"' P < 0.01 compared to the corresponding control. 
* P < 0.05 compared to zero. 
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Fig. 1. Effect of cytochalasin D at different concentrations on the 
transepithelial electrical potential difference (Vm~), shortcircuit current 
(I,¢) and transepithelial electrical resistance (R~v) of nasal mucosa. 
Results reported as means+standard error. Control (n=21):  I1. Cy- 
tochalasin D: 0.1 ixg /ml (n=13)  -; 1 p~g/ml (n= 8) A. *, * *P< 
0.05 or 0.01 compared to the control: +,  + + P < 0.05 or 0.01 com- 
pared to the condition with 0.1 txg/ml inhibitor. 
both net absorptions (CCT alone or on microspheres) were 
abolished, since Tm~, significantly greater than Tsm under 
control conditions, on treatment overlapped ~m" However, 
it is worth noting that: (1) when CCT was presented alone, 
T,m was significantly increased about 2.5 times by treat- 
ment, (2) when CCT was adsorbed on microspheres, T m 
was not significantly modified by the inhibitor. 
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Table 2 
Effect of cytochalasin D (0.1 p~g/ml) on the overall transepithelial 
transport of CCT-covered microspheres during the two experiment hours 
Microsphere transport (106 cm- 2) 
CCT-uncovered CCT-covered 
Control Cytochalasin D 
Tm~ 9.0±0.8 21.9±1.6 °° 11.3±0.6"" 
(6) (9) (6) 
~m 8.3±0.8 10.4±0.7 11.5±0.5 
(6) (9) (6) 
~t  0.7±0.7 11.5± 1.0. * -0.2±0.5 
(6) (9) (6) 
After 30 min preincubation 3.5.1011/ml CCT-uncovered or CCT-covered 
microspheres (polystyrene, 0.5 Ixm diameter) were added to the mucosal 
or submucosal compartment a d the overall corresponding unidirectional 
transports during 2 hours (Tm~, T~m) were determined by a Burker 
chamber. Based on their difference the overall net transport (T.e t) was 
calculated. When present, cytochalasin D was on both sides of the tissue 
during the 30 min preincubation a d 2 h subsequent i cubation. 
Results presented asmeans + S.E. (number of experiments in parenthe- 
ses). 
P < 0.01 compared the respective ~m" 
"" P < 0.01 compared tothe corresponding control. 
* * P < 0.01 compared tozero. 
Fig. 1 reports the effects on Vm~, [~c and Rep elicited by 
treatments with cytochalasin D at different concentrations 
(0.1 and 1 I~g/ml; treatment, as above, on both sides of 
the tissue for the whole experiment, beginning just after 
electrical measurements were taken at zero min time). 
With both inhibitors concentrations Rep proved to be 
significantly reduced after 30 min of treatment, the de- 
crease already being maximal with 0.1 txg/ml inhibitor. 
This result, which indicates an increase in intercellular 
junctional permeability, is in accordance with the reduction 
in junctional resistance observed with cytochalasin B (10 
p~g/ml) in other epithelia, in which it has been shown that 
tight-junction permeability is under cytoskeletal control 
[9]. The same figure also shows that 0.1 Ixg/ml cyto- 
chalasin D does not significantly affect I~c which is an 
index of the active ion transports through the cellular 
pathway (in this epithelium: active Na + absorption, active 
CI-  secretion [10]). It is only with a concentration of 1 
Ixg/ml (2- 10 -6 M) that, after 30 min of treatment, this 
cellular parameter also decreases significantly compared to 
the control. Vm~, which is a function of both Rep and I~c, is 
obviously modified at concentrations of both 0.1 and 1 
~g/ml .  
4. Discussion 
The results obtained show that the three predictions 
reported in Section 1 are all fulfilled. 
Net absorption is also present with elcatonin adsorbed 
on microspheres. This net absorption is specific, as no net 
transfer is observed with CCT-uncovered microparticles 
(which, conversely, should also display a net transfer in 
the presence of pinocytosis). 
As for the third prediction, of the cytochalasins, cyto- 
chalasin D is considered to be the most specific agent on 
actin microfilaments, mainly at the concentration of 0.1 
p~g/ml [4], although it is often used at higher concentra- 
tions. Unlike cytochalasin B, it does not display any 
inhibition on monosaccharide-facilitated transport, which 
supplies glucose to the cellular metabolism [4]. 
The results reported here show that in the nasal mucosa 
0.1 ~zg/ml cytochalasin D does not affect cellular active 
ion transports, which are only modified at higher inhibitor 
concentrations. This fact supports the notion that 
metabolism is not influenced. Nevertheless, at the same 
inhibitor concentration, the net CCT transport is abolished. 
Clearly, this effect cannot be due to cellular ATP deple- 
tion. At a first sight it seems rather to be evidence in favor 
of the presence of vesicular transport supported by the 
actin cytoskeleton. On the other hand, in agreement with 
the findings for other epithelia [9], in the nasal mucosa 
intercellular junction permeability also proves to be regu- 
lated by the actin cytoskeleton: in fact, the transepithelial 
electrical resistance decreases and CCT Tsm increases on 
treatment with 0.1 p~g/ml cytochalasin D. Hence the 
abolition of the net CCT transport apparently might also be 
due to a mere increase in Tsm, with an action of cyto- 
chalasin D only on the actin cytoskeleton regulating tight- 
junctions. However, some considerations are against this 
explanation. 
Tsm is a paracellular/intercellular p ssive unidirectional 
flux; Tr~ ~ has two components, i.e., a paracellular/intercel- 
lular passive unidirectional f ux, equal to Tsm at any situa- 
tion, and a cellular active net flux. If the intercellular 
fraction of Tsm increases owing to the opening of tight- 
junctions, the passive intercellular component of Tm~ also 
increases to the same extent and the overall Tm~ must 
increase. Conversely, in the present case Tm~ is unmodi- 
fied, Jnet disappears and the remaining component of Tm~ 
is the passive one equal to T,m- Thus, concomitantly Tm~ 
has undergone an increase in the passive component (which 
would have increased the overall Tm~) and a decrease of 
the active component (which would have decreased the 
overall Tm~): due to these two opposite changes, Tm~ is 
apparently unmodified. The point is what is the cause of 
the disappearing of the active component of Tm~. One 
possibility is that the cellular active transport is abolished; 
however, it is also possible that it remains, but simply is 
not measurable transepithelially, if the CCT actively trans- 
ported by the cell into the intercellular channels back-dif- 
fuses to the lumen, owing to the tight-junction increased 
permeability. Thus, the results obtained with CCT alone 
cannot lead to a univocal interpretation either for nor 
against the abolition of active transport at the cellular 
level. However, CCT, adsorbed on microspheres, displays 
a T,m which can be only paracellular (owing to the micro- 
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sphere diameter 2) and cannot be affected by changes in 
tight-junction permeability, even if they take place (as 
occurs during cytochalasin D treatment). In this way it is 
possible to observe whether actin cytoskeleton regulates 
directly the active transport, he importance of the effects 
on tight-junctions having been eliminated by the particular 
experimental condition. Actually, with this trim cyto- 
chalasin D does not modify T~m, but equally abolishes Tne t, 
revealing the decrease in Tm~. 
The univocal conclusion is that CCT active transport is 
directly and completely inhibited at the cellular level and 
that the active polypeptide transport previously evidenced 
in the nasal mucosa is supported by specific vesicular 
transport driven by actin microfilaments, probably at the 
apical border of the cell. These conclusions are in agree- 
ment with those reported by a parallel paper in which we 
show that active transport of the polypeptide (presented 
alone to the tissue) is also inhibited by cytochalasin B
(although the possibility of indirect actions in that case 
remains open) and by some typical endocytosis nhibitors 
(colchicine, aluminum fluoride, monensin) [11]. 
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